Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Arch Physiol Biochem ; 122(5): 238-256, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27467289

ABSTRACT

Cause of Parkinson's disease (PD) is still not understood. Motor symptoms are not observed at early stages of disease due to compensatory processes. Dysfunction of mitochondria was indicated already at preclinical PD. Selective toxin 6-OHDA was applied to kill dopaminergic neurons in substantia nigra and disturb neuronal transmission in striatum. Early phase of active degeneration and later stage, when surviving cells adapted to function normally, were analysed. 2D BN/SDS difference gel electrophoresis (DIGE) of mitochondrial proteome enabled to point out crucial processes involved at both time-points in dopaminergic structures. Marker proteins such as DPYSL2, HSP60, ATP1A3, EAAT2 indicated structural remodelling, cytoskeleton rearrangement, organelle trafficking, axon outgrowth and regeneration. Adaptations in dopaminergic and glutamatergic neurotransmission, recycling of synaptic vesicles, along with enlargement of mitochondria mass were proposed as causative for compensation. Changed expression of carbohydrates metabolism and oxidative phosphorylation proteins were described, including their protein-protein interactions and supercomplex assembly.


Subject(s)
Corpus Striatum/metabolism , Disease Models, Animal , Electrophoresis, Gel, Two-Dimensional/methods , Mitochondria/metabolism , Nerve Degeneration/metabolism , Parkinson Disease/metabolism , Proteomics/methods , Substantia Nigra/metabolism , Animals , Corpus Striatum/pathology , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Male , Mitochondria/pathology , Mitochondrial Proteins/metabolism , Nerve Degeneration/pathology , Parkinson Disease/pathology , Proteome/analysis , Proteome/metabolism , Rats , Rats, Wistar , Substantia Nigra/pathology
2.
Biochim Biophys Acta ; 1862(4): 741-753, 2016 04.
Article in English | MEDLINE | ID: mdl-26844379

ABSTRACT

In Parkinson's disease (PD) motor symptoms are not observed until loss of 70% of dopaminergic neurons in substantia nigra (SN), preventing early diagnosis. Mitochondrial dysfunction was indicated in neuropathological process already at early PD stages. Aging and oxidative stress, the main factors in PD pathogenesis, cause membrane stiffening, which could influence functioning of membrane-bound oxidative phosphorylation (OxPhos) complexes (Cxs) in mitochondria. In 6-OHDA rat model, medium-sized dopaminergic lesion was used to study mitochondrial membrane viscosity and changes at the level of OxPhos Cxs and their higher assembled states-supercomplexes (SCxs), during the early degeneration processes and after it. We observed loss of dopaminergic phenotype in SN and decreased dopamine level in striatum (STR) before actual death of neurons in SN. Behavioural deficits induced by lesion were reversed despite progressing neurodegeneration. Along with degeneration process in STR, mitochondrial Cx I performance and amount decreased in almost all forms of SCxs. Also, progressing decrease of Cx IV performance in SCxs (I1III2IV3-1, I1IV2-1) in STR was observed during degeneration. In SN, SCxs containing Cx I increased protein amount and a shifted individual Cx I1 into superassembled states. Importantly, mitochondrial membrane viscosity changed in parallel with altered SCxs performance. We show for the first time changes at the level of mitochondrial membrane viscosity influencing SCxs function after dopaminergic system degeneration. It implicates that altered mitochondrial membrane viscosity could play an important role in regulation of mitochondria functioning and pathomechanisms of PD. The data obtained are also discussed in relation to compensatory processes observed.


Subject(s)
Cell Membrane/metabolism , Dopaminergic Neurons/metabolism , Mitochondria/metabolism , Oxidative Phosphorylation/drug effects , Oxidopamine/adverse effects , Parkinson Disease, Secondary/metabolism , Animals , Cell Membrane/pathology , Dopaminergic Neurons/pathology , Male , Mitochondria/pathology , Mitochondrial Proteins/metabolism , Oxidopamine/pharmacology , Parkinson Disease, Secondary/pathology , Rats , Rats, Wistar
3.
Biochem J ; 452(2): 231-9, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23514110

ABSTRACT

ROS (reactive oxygen species) generated by NADPH oxidases play an important role in cellular signal transduction regulating cell proliferation, survival and differentiation. Nox4 (NADPH oxidase 4) induces cellular senescence in human endothelial cells; however, intracellular targets for Nox4 remained elusive. In the present study, we show that Nox4 induces mitochondrial dysfunction in human endothelial cells. Nox4 depletion induced alterations in mitochondrial morphology, stabilized mitochondrial membrane potential and decreased production of H(2)O(2) in mitochondria. High-resolution respirometry in permeabilized cells combined with native PAGE demonstrated that Nox4 specifically inhibits the activity of mitochondrial electron transport chain complex I, and this was associated with a decreased concentration of complex I subunits. These data suggest a new pathway by which sustained Nox4 activity decreases mitochondrial function.


Subject(s)
Electron Transport Complex I/antagonists & inhibitors , NADPH Oxidases/chemistry , NADPH Oxidases/physiology , Electron Transport Complex I/chemistry , Endothelial Cells/metabolism , Gene Knockdown Techniques , Human Umbilical Vein Endothelial Cells , Humans , Membrane Potential, Mitochondrial , Mitochondria/enzymology , Mitochondria/metabolism , Mitochondria/pathology , NADPH Oxidase 4 , NADPH Oxidases/deficiency , Oxidative Phosphorylation , Oxygen Consumption , Protein Subunits/antagonists & inhibitors , Protein Subunits/chemistry , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/chemistry , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL